Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Rotte

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019
Combination of CTLA-4 and PD-1 blockers for treatment of cancerAnand Rotte
Annals of Translational Medicine|April 3, 2023
Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentaryAnand Rotte
Current Gene Therapy|April 27, 2024
Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesAnand Rotte
Frontiers in Oncology|April 30, 2024
Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and moreAnand Rotte
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future StrategiesMadhuri Bhandaru, Anand Rotte
Biomedicines|September 28, 2021
Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical DevelopmentAnand Rotte, Srikumar Sahasranaman, Nageshwar Budha
Cellular Oncology (Dordrecht, Netherlands)|June 7, 2012
MMP2 expression is a prognostic marker for primary melanoma patientsAnand Rotte, Magdalena Martinka, Gang Li
Apoptosis : an International Journal on Programmed Cell Death|November 19, 2013
Tumor suppressor Ing1b facilitates DNA repair and prevents oxidative stress induced cell deathAnand Rotte, Gang Li, Madhuri Bhandaru
Journal of Pain Research|September 1, 2021
Decreased Opioid Consumption and Durable Pain Relief in Patients Treated with 10 kHz SCS: A Retrospective Analysis of Outcomes from Single-CenterHonghui Feng, Patrick Doherty, Anand Rotte
Journal of Experimental & Clinical Cancer Research : CR|November 1, 2018
Nobel committee honors tumor immunologistsAnand Rotte, Gabriella D'Orazi, Madhuri Bhandaru
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019
Combination of CTLA-4 and PD-1 blockers for treatment of cancerAnand Rotte
Annals of Translational Medicine|April 3, 2023
Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentaryAnand Rotte
Current Gene Therapy|April 27, 2024
Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesAnand Rotte
Frontiers in Oncology|April 30, 2024
Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and moreAnand Rotte
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future StrategiesMadhuri Bhandaru, Anand Rotte
Biomedicines|September 28, 2021
Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical DevelopmentAnand Rotte, Srikumar Sahasranaman, Nageshwar Budha
Cellular Oncology (Dordrecht, Netherlands)|June 7, 2012
MMP2 expression is a prognostic marker for primary melanoma patientsAnand Rotte, Magdalena Martinka, Gang Li
Apoptosis : an International Journal on Programmed Cell Death|November 19, 2013
Tumor suppressor Ing1b facilitates DNA repair and prevents oxidative stress induced cell deathAnand Rotte, Gang Li, Madhuri Bhandaru
Journal of Pain Research|September 1, 2021
Decreased Opioid Consumption and Durable Pain Relief in Patients Treated with 10 kHz SCS: A Retrospective Analysis of Outcomes from Single-CenterHonghui Feng, Patrick Doherty, Anand Rotte
Journal of Experimental & Clinical Cancer Research : CR|November 1, 2018
Nobel committee honors tumor immunologistsAnand Rotte, Gabriella D'Orazi, Madhuri Bhandaru
Pageof 8